Publicaciones en las que colabora con Manuel Díez Alonso (26)

1997

  1. Prediction of recurrence by quantification of p185(neu) protein in non-small cell lung cancer tissue

    British Journal of Cancer, Vol. 75, Núm. 5, pp. 684-689

  2. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: Rationale of sequential processing of frozen and paraffin-embedded tissue

    World Journal of Surgery, Vol. 21, Núm. 3, pp. 323-329

1996

  1. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma

    Cancer, Vol. 77, Núm. 6, pp. 1066-1072

  2. Colorectal cancer: Has its diagnosis improved in the last decade?

    Revista Espanola de Enfermedades Digestivas, Vol. 88, Núm. 1, pp. 26-28

  3. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer

    British Journal of Cancer, Vol. 73, Núm. 10, pp. 1248-1254

1995

  1. Concordance between serum and cytosolic levels of CEA CA125 and SCC antigens in patients with non-small cell lung cancer

    Anticancer Research, Vol. 15, Núm. 6 B, pp. 2811-2817

  2. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer

    International Journal of Biological Markers, Vol. 10, Núm. 1, pp. 5-10

  3. Valor pronóstico de variables predictivas comunes en el cáncer de recto.

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 87, Núm. 3, pp. 205-210

1994

  1. Epidermal growth factor receptor in non-small cell cancer of the lung

    Archivos de bronconeumología, Vol. 30, Núm. 6, pp. 282-286

  2. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma

    Anticancer Research, Vol. 14, Núm. 6 B, pp. 2819-2825

  3. Prognostic significance of serum ca 125 antigen assay in patients with non‐small cell lung cancer

    Cancer, Vol. 73, Núm. 5, pp. 1368-1376

  4. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non‐small cell lung cancer

    Cancer, Vol. 73, Núm. 9, pp. 2305-2311

  5. Resultados tras resección radical ampliada por carcinoma colorrectal localmente avanzado.

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 85, Núm. 6, pp. 435-439

1993

  1. UTILIDAD DEL ANTIGENO CA 125 EN SUERO COMO FACTOR PRONOSTICO DE SUPERVIVENCIA EN PACIENTES CON CARCINOMA PULMONAR NO MICROCITICO

    Neoplasia, Vol. 10, Núm. 6, pp. 192-196

  2. Value of serum neuron-specific enolase in nonsmall cell lung cancer

    Oncology, Vol. 50, Núm. 2, pp. 127-131

1991

  1. Continent colostomy by means of a new one-piece disposable device - Preliminary report

    Diseases of the Colon & Rectum, Vol. 34, Núm. 10, pp. 886-890

  2. Evaluation of serum ca 125 as a tumor marker in non‐small cell lung cancer

    Cancer, Vol. 67, Núm. 1, pp. 150-154

1990

  1. Tumor markers in pancreatic cancer: A comparative clinical study between CEA, CA 19-9 and CA 50

    International Journal of Biological Markers, Vol. 5, Núm. 3, pp. 127-132

1989

  1. Serum and tissue trace metal levels in lung cancer

    Oncology, Vol. 46, Núm. 4, pp. 230-234

  2. Use of the copper/zinc ratio in the diagnosis of lung cancer

    Cancer, Vol. 63, Núm. 4, pp. 726-730